Details

Autor(en) / Beteiligte

• Szigethy, Eva, MD, PhD
• Bujoreanu, Simona I., PhD
• Youk, Ada O., PhD
• Weisz, John, PhD
• Benhayon, David, MD, PhD
• Fairclough, Diane, DrPh
• Ducharme, Peter, LICSW
• Gonzalez-Heydrich, Joseph, MD
• Keljo, David, MD
• Srinath, Arvind, MD
• Bousvaros, Athos, MD
• Kirshner, Margaret, BA
• Newara, Melissa, MS
• Kupfer, David, MD
• DeMaso, David R., MD

Titel

Randomized Efficacy Trial of Two Psychotherapies for Depression in Youth With Inflammatory Bowel Disease

Ist Teil von

• Journal of the American Academy of Child and Adolescent Psychiatry, 2014-07, Vol.53 (7), p.726-735

Ort / Verlag

Maryland Heights, MO: Elsevier Inc

Erscheinungsjahr

2014

Quelle

Applied Social Sciences Index & Abstracts (ASSIA)

Beschreibungen/Notizen

• Objective Pediatric inflammatory bowel disease (IBD) is associated with high rates of depression. This study compared the efficacy of cognitive behavioral therapy (CBT) to supportive nondirective therapy (SNDT) in treating youth with comorbid IBD and depression. Method Youth (51% female and 49% male; age 9–17 years, mean age 14.3 years) with depression and Crohn's disease (n = 161) or ulcerative colitis (n = 56) were randomly assigned to a 3-month course of CBT or SNDT. The primary outcome was comparative reduction in depressive symptom severity; secondary outcomes were depression remission, increase in depression response, and improved health-related adjustment and IBD activity. Results A total of 178 participants (82%) completed the 3-month intervention. Both psychotherapies resulted in significant reductions in total Children's Depression Rating Scale Revised score (37.3% for CBT and 31.9% for SNDT), but the difference between the 2 treatments was not significant ( p  = .16). There were large pre–post effect sizes for each treatment (d = 1.31 for CBT and d = 1.30 for SNDT). More than 65% of youth had a complete remission of depression at 3 months, with no difference between CBT and SNDT (67.8% and 63.2%, respectively). Compared to SNDT, CBT was associated with a greater reduction in IBD activity ( p  = .04) but no greater improvement on the Clinical Global Assessment Scale ( p  = .06) and health-related quality of life (IMPACT-III scale) ( p  = .07). Conclusion This is the first randomized controlled study to suggest improvements in depression severity, global functioning, quality of life, and disease activity in a physically ill pediatric cohort treated with psychotherapy. Clinical trial registration information—Reducing Depressive Symptoms in Physically Ill Youth; http://clinical trials.gov ; NCT00534911.